Does the small tyrosine kinase inhibitor imatinib mesylate counteract diabetes by affecting pancreatic islet amyloidosis and fibrosis?
Author:
Publisher
Informa Healthcare
Subject
Pharmacology (medical),Pharmacology,General Medicine
Link
http://www.tandfonline.com/doi/pdf/10.1517/13543784.2012.724398
Reference80 articles.
1. The Bcr-Abl tyrosine kinase inhibitor imatinib and promising new agents against Philadelphia chromosome-positive leukemias
2. Tyrosine kinase oncogenes in normal hematopoiesis and hematological disease
3. Autoinhibition of c-Abl
4. Activation of the c-Abl tyrosine kinase in the stress response to DMA-damaging agents
Cited by 8 articles. 订阅此论文施引文献 订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献
1. Are off-target effects of imatinib the key to improving beta-cell function in diabetes?;Upsala Journal of Medical Sciences;2022-09-14
2. Synergistic Effects of Milk-Derived Exosomes and Galactose on α-Synuclein Pathology in Parkinson’s Disease and Type 2 Diabetes Mellitus;International Journal of Molecular Sciences;2021-01-21
3. Expert opinion on the metabolic complications of new anticancer therapies: Tyrosine kinase inhibitors;Annales d'Endocrinologie;2018-10
4. Mechanisms through which diabetes mellitus influences renal cell carcinoma development and treatment: A review of the literature;International Journal of Molecular Medicine;2016-10-17
5. Tyrosine Kinase Inhibitors and Diabetes: A Novel Treatment Paradigm?;Trends in Endocrinology & Metabolism;2015-11
1.学者识别学者识别
2.学术分析学术分析
3.人才评估人才评估
"同舟云学术"是以全球学者为主线，采集、加工和组织学术论文而形成的新型学术文献查询和分析系统，可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容，当前同舟云学术共收录了国内外主流学术期刊6万余种，收集的期刊论文及会议论文总量共计约1.5亿篇，并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询！咨询电话：010-8811{复制后删除}0370
www.globalauthorid.com
TOP
Copyright © 2019-2024 北京同舟云网络信息技术有限公司 京公网安备11010802033243号 京ICP备18003416号-3